Latest

COVID-19

Featured Genetics Neuroscience Open Neuroscience Articles

·April 22, 2020·7 min read

Cells in lungs, nasal passage, and intestines more susceptible to COVID-19 infection

Researchers have identified specific cell types that appear to be the main targets of SARS-CoV-2, the virus that causes COVID-19. Using existing data on the RNA found in different types of cells, researchers were able to identify cells that expressed ACE2 and TMPRSS2, two proteins that assist coronavirus to enter human cells. Cells in the lungs, nasal passage and intestines appear to be the main targets for SARS-CoV-2.

Featured Genetics Neuroscience

·April 22, 2020·4 min read

Using ‘elite’ antibodies from COVID-19 survivors to develop potent therapies

Researchers are sifting through millions of antibodies produced by those who have recovered from COVID-19 to find which ones neutralize the virus. The team has already identified several antibodies that block coronavirus from interacting with its receptors.

Featured Neuroscience Open Neuroscience Articles

·April 21, 2020·3 min read

Biosensor detects coronavirus from nasopharyngeal swabs in less than one minute

Researchers have developed a new biosensor that can detect SARS-CoV-2, the virus that leads to COVID-19, from nasopharyngeal swabs in under one minute.

Featured Neuroscience

·April 21, 2020·3 min read

Understanding the ‘symptom-less’ COVID-19 carriers key to stopping spread

Increasing COVID-19 testing to include those who are asymptomatic is key to combatting the spread of coronavirus.

Featured Neuroscience

·April 20, 2020·3 min read

Early antibody testing results reveal more COVID-19 infections than confirmed cases

The first round of antibody testing in L.A country reveals approximately 4.1% of the adult population has COVID-19 antibodies. Adjusting for margin of error, between 2.8% to 5.6% of the adult population has antibodies to the virus. This means between 221,000 and 442,000 adults in the Los Angeles area have been infected with coronavirus. The estimate is up to 55 times higher than confirmed cases reported for the area.

Featured Neuroscience

·April 20, 2020·3 min read

Remdesivir prevents disease progression in monkeys with COVID-19

Macaque monkeys infected with mild-to-moderate coronavirus responded well to the antiviral Remdesivir. Researchers report the monkeys showed reduced clinical symptoms and less lung damage when the drug was administered. The findings back up other reports which claim the drug is effective at treating human COVID-19 infections in current clinical trials.

Featured Neuroscience

·April 20, 2020·5 min read

Slower Clearance of Coronavirus Infection May Explain Why Men Fare Worse Than Women

A new study seeks to explain why men infected by coronavirus generally show more severe symptoms and have an increased risk of death over women. Focusing on ACE2 receptors, researchers found the testes, along with the lungs and kidneys, were among areas of the body with the highest ACE2 expression. ACE2 could not be detected in ovarian tissue. The findings back up a previous study that reported male COVID-19 patients experienced impaired testicular function. This suggests the testes may be significantly affected when men develop coronavirus.

Featured Neuroscience Neuroscience Videos

·April 20, 2020·7 min read

Live virus used to identify 30 existing drugs that could successfully treat COVID-19

27 existing drugs which are currently not under evaluation for COVID-19 are effective at halting the replication of SARS-CoV-2. Four of the drugs, apilimod, MLN-3897, VBY-825, and ONO 5334, which have previously been tested for the treatment of a range of diseases from rheumatoid arthritis to cancer, appear to be the best candidates for coronavirus treatment.

Featured Genetics Neuroscience

·April 18, 2020·3 min read

Individual genetic variation in immune system may affect severity of COVID-19

Study reveals genetic variability in the immune system could affect susceptibility to coronavirus infection and govern the severity of the disease for those infected.

Featured Neuroscience Open Neuroscience Articles

·April 18, 2020·2 min read

WHO recommended disinfectants are easy to make and effective against COVID-19

Are you finding it hard to find hand sanitizers in the wake of COVID-19? The WHO has provided a recommended formula to make your own hand disinfectants that can kill the SARS-CoV-2 virus within 30 seconds.

Featured Neuroscience

·April 17, 2020·4 min read

COVID-19 striking more children than expected

Researchers report the number of children infected with COVID-19 is far more extensive than being reported. For every child that requires hospitalization and ICU care for coronavirus, there are 2,381 other children infected with the virus.

Featured Neuroscience

·April 17, 2020·6 min read

AI predicts when coronavirus infections will slow in each country

A new machine learning model uses data from the COVID-19 pandemic in conjunction with a neural network and can determine the efficacy of social distancing measures and better predict viral spread. With current quarantine measures in place, the AI model predicts a plateau in coronavirus infections between April 15-20.